Effect of Ingestion of Human, Cow, and Modified-cow Milk, on Glucose and Hormone Responses in Humans.

Insulin Tolerance Clinical Trial

— PROLAT  

Official title:

Study of the Effects of Ingestion of Natural Human, Natural Cow, and Modified-cow Milk, on Glucose, Amino Acids, Insulin, and Incretin Responses in Humans

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04698889
• Other study ID #: Tessari Protocol 1
• Status: Completed
• Phase: N/A
• Start date: April 7, 2015
• Est. completion date: October 1, 2020

Study information

• Verified date: January 2021
• Source: University of Padova
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Human milk, despite a much lower protein content, is as effective as cow milk on insulin stimulation under iso-lactose conditions. The causes for such a similar potency are unknown. This effect could be due to incretin and amino-acid responses, and/or to milk-protein interactions.In this study the investigators will address the above question(s) by testing, in young healthy volunteers, the effects of natural cow and human milk, as well as of the manipulation of the casein and whey protein content in cow milk, on insulin, C-peptide, GLP-1 and GIP secretion, as well as on circulating amino acids.

Description:

Objective: To determine plasma glucose, insulin, C-peptide, glucagon-like polypeptide-1 (GLP-1), glucose-inhibitory-polypeptide (GIP) and amino-acid responses, following administration of human and cow milk, either natural or with experimentally-modified casein and whey-protein content(s).

Design. Young healthy volunteers of both sexes will receive iso-lactose loads (0.36 g lactose / kg body weight) of: natural cow milk; natural human milk; and of cow milk with modified casein and whey protein contents. Blood samples will be frequently collected over 4 hours. Plasma glucose, amino acids, insulin and incretin concentrations will be measured.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 17
• Est. completion date: October 1, 2020
• Est. primary completion date: February 5, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 35 Years

Eligibility

Inclusion Criteria:

• Age 20-35 yrs

• Both sexes

• Healthy

• In post-absorptive state

• Hemoglobin Hb1c values within normal values.

• Previous regular, moderate physical activity

• Stable body weight and regular dietary habits.

Exclusion Criteria:

• Familial or personal history of diabetes.

• Altered fasting glucose and/ or impaired glucose tolerance.

• Any metabolic, hormonal, hepatic, renal, and cardiovascular disease.

• Current drug treatments

Related Conditions & MeSH terms

• Aminoacidaemia
• Hormone
• Insulin Tolerance

Intervention

Dietary Supplement:
• natural cow

• high protein cow milk

• natural human

• low protein cow milk

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Padova

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Plasma insulin and c-peptide	microunits and nanomoles	1 year
Primary	Plasma GIP: glucose-inhibitory polypeptide and GLP-1: glucagon-like-polypeptide-1	picomol/L and picogram/mL	1 year
Secondary	Plasma Amino acids	micromol/L	2 years